In a bold move that underscores its ambitions in the global medical technology sector, India-based Zydus Lifesciences Ltd. has announced a blockbuster agreement to acquire French orthopedic powerhouse Amplitude Surgical SA. The deal, valued at €256.8 million ($280 million), will see Zydus take control of the company in phases, marking a pivotal expansion into the European market.
The acquisition agreement was struck with PAI Partners, the private equity giant that currently owns a significant stake in Amplitude Surgical, along with key management and other minority shareholders.
A Two-Stage Takeover: Zydus Tightens Its Grip
In the first stage of the deal, Zydus will acquire an 85.6% interest in Amplitude Surgical. Following this, the Indian firm will move to secure the remaining stake at €6.25 per share, leading to a full delisting of Amplitude Surgical from Euronext Paris—a decisive step in solidifying its control.
The €6.25-per-share valuation represents a jaw-dropping 80.6% premium over the previous day’s closing price, a clear testament to Zydus’ confidence in Amplitude Surgical’s growth trajectory.
